PDCD1 and B-cell non-Hodgkin lymphoma: Blockade of the PD-1/PD-L1 axis has led to meaningful responses in B-cell non-Hodgkin lymphomas with an overall response rate of 36% for DLBCL and 40% for follicular lymphoma (FL) [16,27,28].